|Articles|September 22, 2022
COVID-19 Agent Molnupiravir
Author(s)YMC Europe GmbH
Molnupiravir, which is a prodrug, and its active agent β-d-N4-hydroxycytidine can be separated by using a YMC-Triart C18 UHPLC column and a MS-compatible mobile phase.
Related Content
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
GC-MS Detection of Microbes in Spacecraft Water
3
GC-MS & GC-IMS Reveal Black Tea Aroma Secrets
4
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
5